The global enteral feeding formulas market size is predicted to grow around USD 12.51 billion by 2033, growing at a CAGR of 5.59% from 2024 to 2033.
Key Points
- The North America enteral feeding formulas market size was estimated at USD 2.32 billion in 2023 and is expected to surpass around USD 4 billion by 2033.
- North America held the largest market share of 32% in 2023.
- By product, the standard formula segment dominated the market with the largest market share of 58% in 2023.
- By flow type, intermittent feeding flow segment has captured the largest market share of 90% in 2023.
- By stage, the adult segment has accounted for the largest share of 91% in 2023.
- By indication, the cancer care segment held a significant share of the market in 2023.
- By sales channel, the institutional segments dominated the market with the highest market share of 52% in 2023.
- By end use, the home care segment is expected to grow at the fastest CAGR of 5.92% over the forecast period.
The enteral feeding formulas market involves the production and distribution of specialized nutritional formulas designed for patients who require tube feeding. This includes patients who cannot eat normally due to medical conditions affecting the digestive system, swallowing difficulties, or severe illness. The market is expanding as the prevalence of chronic diseases and the aging population increase the need for medical nutrition support.
Get a Sample: https://www.precedenceresearch.com/sample/4123
Growth Factors
The enteral feeding formulas market is experiencing growth due to several factors, including the rising incidence of chronic diseases such as cancer, diabetes, and neurological disorders that often require specialized nutritional support. Additionally, the growing elderly population worldwide is driving demand for enteral nutrition. Technological advancements in enteral feeding products and an increased focus on patient care also contribute to market growth.
Region Insights
Geographically, the enteral feeding formulas market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is a leading market due to advanced healthcare infrastructure, high healthcare spending, and a large aging population. Europe follows closely, with a strong presence of key market players and a significant focus on research and development. The Asia-Pacific region is anticipated to grow rapidly, driven by increasing healthcare investments, rising disposable income, and growing awareness about enteral nutrition.
Enteral Feeding Formulas Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 5.59% |
| Global Market Size in 2023 | USD 7.26 Billion |
| Global Market Size in 2024 | USD 7.67 Billion |
| Global Market Size by 2033 | USD 12.51 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Flow Type, By Stage, By Indication, By End-use, and By Sales Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Enteral Feeding Formulas Market Dynamics
Drivers
Key drivers for the enteral feeding formulas market include the growing prevalence of chronic illnesses, an aging global population, and the rising demand for home-based enteral nutrition care. Additionally, increased investments in healthcare infrastructure and technological advancements in enteral feeding devices and formulations are expected to boost market growth.
Opportunities
The market offers several opportunities for growth, such as the development of innovative, nutrient-rich formulations and personalized nutrition options. Companies can also expand their market share by focusing on emerging markets with growing healthcare investments and unmet medical needs. Strategic partnerships and acquisitions can provide a competitive edge and help broaden product portfolios.
Challenges
Despite the positive growth outlook, the enteral feeding formulas market faces challenges such as stringent regulatory approvals, high costs associated with enteral feeding, and potential complications related to tube feeding. Additionally, competition from alternative feeding methods and concerns about reimbursement policies may pose challenges for market players. Companies need to navigate these obstacles to maintain growth and competitiveness.
Read Also: Dental Compressors Market Size to Rise USD 620.95 Mn by 2033
Enteral Feeding Formulas Market Recent Developments
- In September 2023, Abbott announced the plan to boost the manufacturing of various adult enteral formulas for the retail market to counteract low supply in the institutional sector.
- In February 2023, Nestlé and EraCal Therapeutics initiated a research collaboration to identify novel nutraceuticals for controlling food intake.
- In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now offered in chocolate. This product is designed to assist in weight gain, weight maintenance, and improved tolerance while providing a delicious taste.
- In September 2022, Kate Farms raised $75 million in a Series C funding round led by life-science investor Novo Holdings. With this, Kate Farms will be able to increase its efforts in developing plant-based clinical nutrition research, product innovation, and development into more channels.
Enteral Feeding Formulas Market Companies
- Nestlé S.A.
- Abbott Laboratories
- Mead Johnson Nutrition Company
- Fresenius Kabi AG
- Danone S.A.
- Victus Inc.
- Hormel Foods, LLC
- B. Braun Melsungen AG
- Global Health Product Inc.
- Aveanna Healthcare
- Meiji Holdings Co., Ltd.
- Nutricia
Segments Covered in the Report
By Product
- Standard Formula
- Disease-specific Formulas
- Alzheimer’s
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others
By Flow Type
- Intermittent Feeding Flow
- Continuous Feeding Flow
By Stage
- Adults
- Pediatrics
By Indication
- Alzheimer’s
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others
By End-use
- Hospitals
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
- Home Care
- Long-Term Care Facilities
By Sales Channel
- Online Sales
- Retail Sales
- Institutional Sales
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/
